CRISPR-Cas9 Technology Cuts Clutter from Sequencing Libraries

In a new article from Genetic Engineering & Biotechnology News (GEN), Gail Dutton speaks with Yaron Hakak, Jumpcode Genomics CEO, on how our CRISPRclean® technology can cut the clutter from sequencing libraries. Much of the information generated by next-generation sequencing is biologically uninformative, but this information keeps filling NGS libraries anyway, creating background noise and […]

Read More

Jumpcode Genomics Expands Team with Appointment of Three Executives

Welcomes Vice President of Research and Development, Vice President of Marketing and Vice President of Sales to fuel innovation and growth SAN DIEGO, Calif. — Jumpcode Genomics, a genome technology platform company focused on enabling genomic analysis, today announced the appointment of three new key hires to its growing team. Jon Armstrong joins the company […]

Read More

TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test

In a new article from GenomeWeb, Senior Editor Christie Rizk speaks with Nicholas Schork, Ph.D., Deputy Director and Distinguished Professor of Quantitative Medicine at The Translational Genomics Research Institute, about how Jumpcode’s CRISPRclean® technology is helping researchers build a better COVID-19 test: While COVID-19 held the world in its grip throughout much of 2020, the […]

Read More

Jumpcode Genomics Secures $21M in Series B Funding

Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, CA – Jumpcode Genomics – a genome technology company focused on improving the understanding […]

Read More

Q&A: A Jump to the Next Step in Sequencing

Jumpcode details how its CRISPRclean tech unites NGS and CRISPR/Cas editing Kelsey Kaustinen details how Jumpcode’s CRISPRclean technology unites NGS and CRISPR/Cas editing in a Q&A with our Chief Scientist, Dr. Stanley Nelson, in the current issue of Drug Discovery News. Read on to hear Dr. Nelson’s perspective on how CRISPRclean can benefit life sciences […]

Read More

Jumpcode Genomics Exits Stealth Mode, Unveils Technology That Addresses the ‘Needle in the Haystack’ Problem of Molecular Biology

Patented CRISPRclean® Technology is a Foundational Tool that Improves the Performance of Next-Generation Sequencing and Other Molecular Workflows by Increasing Sensitivity, Reducing Costs and Enabling Novel Discovery CARLSBAD, Calif. – Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and announced […]

Read More
1 2 3